Ahmed Mohamed Taha Abdelhak, MD
|
| Title(s) | Postdoctoral Scholar, Neurology |
|---|
| School | School of Medicine |
|---|
| Address | 675 Nelson Rising Lane
San Francisco CA 94158
|
|---|
| Phone | -- |
|---|
ORCID
.gif) | 0000-0001-9731-4169  |
|---|
| vCard | Download vCard |
|---|
|
|
Biography
| Ain Shams University , Cairo, Egypt | MD | 2010 | Human Medicine |
| University of Ulm, Ulm, Germany | Doctor of Medicine (PhD equivalent) | 2017 | Clinical Neurology |
| University of Bordeaux, Bordeaux, France | MS.c | 2019 | Neuroscience |
| German Medical Board, Stuttgart, Germany | German Neurology Board Certification | 2022 | Clinical Neurology |
| German Multiple Sclerosis Society | 2018
-
| 2020 | EmBioProMS |
| German Multiple Sclerosis Society, German Multiple Sclerosis Trust | 2020
-
| 2023 | EmBioProMS |
| Weill institute for neurosciences | 2021
-
| 2022 | Establishing novel blood-based biomarkers to track MS activity |
Overview
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 Jun 16.
Abdelhak A, Cordano C, Boscardin WJ, Caverzasi E, Kuhle J, Chan B, Gelfand JM, Yiu HH, Oertel FC, Beaudry-Richard A, Condor Montes S, Oksenberg JR, Lario Lago A, Boxer A, Rojas-Martinez JC, Elahi FM, Chan JR, Green AJ. PMID: 35710320.
View in:
PubMed Mentions:
-
Reply to "Interpretation of Longitudinal Changes of the Inner Nuclear Layer in MS". Ann Neurol. 2022 Apr 11.
Cordano C, Yiu HH, Abdelhak A, Beaudry-Richard A, Oertel FC, Green AJ. PMID: 35403744.
View in:
PubMed Mentions:
-
Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022 03; 18(3):158-172.
Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D'Anna L, Huss A, Oeckl P, Ludolph AC, Kuhle J, Petzold A, Manley GT, Green AJ, Otto M, Tumani H. PMID: 35115728.
View in:
PubMed Mentions:
-
Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review. J Stroke Cerebrovasc Dis. 2022 Mar; 31(3):106292.
Foschi M, Padroni M, Abu-Rumeileh S, Abdelhak A, Russo M, D'Anna L, Guarino M. PMID: 35026496.
View in:
PubMed Mentions:
-
Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 06 22; 144(5):e44.
Foschi M, D'Anna L, Abdelhak A, Mayer B, Tumani H, Otto M, Abu-Rumeileh S. PMID: 33822000; PMCID: PMC8083498.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Cells. 2020 11 25; 9(12).
Robinson T, Abdelhak A, Bose T, Meinl E, Otto M, Zettl UK, Dersch R, Tumani H, Rauer S, Huss A. PMID: 33255854; PMCID: PMC7761295.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies. Biomedicines. 2020 Aug 28; 8(9).
Huss A, Senel M, Abdelhak A, Mayer B, Kassubek J, Ludolph AC, Otto M, Tumani H. PMID: 32872144; PMCID: PMC7555392.
View in:
PubMed Mentions:
1
-
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021 Apr; 268(4):1133-1170.
Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. PMID: 32840686; PMCID: PMC7445716.
View in:
PubMed Mentions:
51 Fields:
Translation:
Humans
-
A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course. Front Neurol. 2020; 11:608.
Huss A, Otto M, Senel M, Ludolph AC, Abdelhak A, Tumani H. PMID: 32765393; PMCID: PMC7378743.
View in:
PubMed Mentions:
1
-
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study. Contemp Clin Trials Commun. 2020 Jun; 18:100574.
Abdelhak A, Huss A, Stahmann A, Senel M, Krumbholz M, Kowarik MC, Havla J, Kümpfel T, Kleiter I, Wüstinger I, Zettl UK, Schwartz M, Roesler R, Friede T, Ludolph AC, Ziemann U, Tumani H. PMID: 32478196; PMCID: PMC7251538.
View in:
PubMed Mentions:
-
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? Front Neurol. 2019; 10:280.
Abdelhak A, Hottenrott T, Morenas-Rodríguez E, Suárez-Calvet M, Zettl UK, Haass C, Meuth SG, Rauer S, Otto M, Tumani H, Huss A. PMID: 30972011; PMCID: PMC6443875.
View in:
PubMed Mentions:
16
-
Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep. 2018 10 04; 8(1):14798.
Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M. PMID: 30287870; PMCID: PMC6172254.
View in:
PubMed Mentions:
33 Fields:
Translation:
Humans
-
Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients. Ann Neurol. 2018 05; 83(5):1032-1036.
Huss A, Abdelhak A, Halbgebauer S, Mayer B, Senel M, Otto M, Tumani H. PMID: 29665046.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation. 2018 Mar 19; 15(1):88.
Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B. PMID: 29554927; PMCID: PMC5859439.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCells
-
CSF profile in primary progressive multiple sclerosis: Re-exploring the basics. PLoS One. 2017; 12(8):e0182647.
Abdelhak A, Hottenrott T, Mayer C, Hintereder G, Zettl UK, Stich O, Tumani H. PMID: 28797088; PMCID: PMC5552348.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Primary Progressive Multiple Sclerosis: Putting Together the Puzzle. Front Neurol. 2017; 8:234.
Abdelhak A, Weber MS, Tumani H. PMID: 28620346; PMCID: PMC5449443.
View in:
PubMed Mentions:
11
-
Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis? Int J Mol Sci. 2015 Jul 31; 16(8):17565-88.
Abdelhak A, Junker A, Brettschneider J, Kassubek J, Ludolph AC, Otto M, Tumani H. PMID: 26263977; PMCID: PMC4581209.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 4 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs